Profile cover photo
Profile photo
ReAnima Advanced Biosciences
99 followers
99 followers
About
Posts

Post has attachment
US-based biotech companies Bioquark and Revita Life Sciences have been given ethical approval to try and bring dead people back to life. Scientists will recruit 20 patients to the trial, all of which have been declared clinically dead from a traumatic brain injury, to see if parts of their central nervous system can be brought back to life. Is it possible to bring dead people back to life by regenerating their brains? We look at the groundbreaking medical trial on the Lip News with Elliot Hill and Joya Mia Italiano.
Add a comment...

Post has attachment
Reanimation Treatment/ Midweek Open Lines
In the first half, CEO of Bioquark, Ira S. Pastor, who has 30 years of experience across multiple sectors of the pharmaceutical industry, discussed his latest work on the re-establishment of life after confirmed brain death using both biological and physical methods to stimulate nerves and awaken patients (related site). Their experimental study is inspired by organisms that can regenerate substantial parts of their bodies such as salamanders. The initial study will involve 20 patients that meet the current brain-death criteria-- in an irreversible coma, on cardiopulmonary support (breathing machine), and are classified as "living cadavers," he detailed.

Using the tools of regenerative medicine, the patients will be injected with stem cells, and a set of peptides developed by Bioquark that are designed to enhance the stem cells. The experiment will take place at an acute long term care facility in India, where the medical costs can be more controlled, he said. There's been a lot of interest in the study among families with comatose patients, and at the end of their first phase, Pastor hopes to see evidence of both neural and vascular regeneration in the lower brain stem-- the area of the brain that is typically required for independent breathing and heartbeat.

"Ultimately, we envision what we'll call a complete reanimation event, but that's not going to happen in six weeks. Nonetheless, this is a step along that path," he explained. Pastor also talked about the current pharmaceutical model for developing drugs, which is seldom cure-oriented, but rather seeks to alleviate the symptoms of various diseases, which often have different and complex pathways and causes.

--------------------------

Midweek Open Lines followed in the latter half, with a number of callers sharing their 'demon' stories. A father recounted a tale of his 9-year-old daughter, who, while playing in their basement, saw a man with all black eyes standing at the top of the stairs, dressed in 19th century garb. Tony from Texas described a strange experience on a road trip, when he felt himself mind probed as a blacked-out vehicle passed them on the highway. Nicole told of living in a haunted hotel in Bridgeport, California, and experiencing an eerie rattling of all the windows.

Thank for watching!
Add a comment...

Post has attachment
U.S. biotech firm Bioquark recently got approval to move forward with its ReAnima Project, in which it will try to reverse brain death in patients on life support.
Add a comment...

Post has attachment

Post has attachment

Post has attachment

Post has attachment

Post has attachment

Post has attachment
Add a comment...

Post has attachment
Add a comment...
Wait while more posts are being loaded